Medical Journals

The Humoral Immune Response and Protective Efficacy of Vaccination with Inactivated Split and Whole Influenza Virus Vaccines in Balb/C Mice.

Authors:
  • Cox Rebecca Jane
  • Hovden Arnt-Ove
  • Brokstad Karl Albert
  • Szyszko Ewa
  • Madhun Abdullah Sami
  • Haaheim Lars Reinhardt

From: Influenza Centre, The Gade Institute, University of Bergen, N-5021 Bergen, Norway. rebecca.cox@gades.uib.no

Vaccine

  • Publish Date: Nov 2006
  • ISSN: 0264-410X
  • Volume: 24
  • Issue: 44-46
  • Pages: 6585-7
  • Medium: Print
  • Language: English
  • Citation (JAMA): Cox Rebecca Jane, Hovden Arnt-Ove, Brokstad Karl Albert, et al. The Humoral Immune Response and Protective Efficacy of Vaccination with Inactivated Split and Whole Influenza Virus Vaccines in Balb/C Mice.. Vaccine Nov 2006;24:6585-7

Abstract

Recently the urgency of developing a pandemic influenza vaccine has lead to the re-evaluation of the use of whole virus vaccine. We have compared the humoral immune response and the protective efficacy of whole and split influenza virus vaccines in mice. Whole virus vaccine was more immunogenic particularly after the first dose of vaccine, generally eliciting higher numbers of systemic antibody secreting cells and an earlier and higher neutralising antibody response. Immunisation with one dose of whole virus vaccine more effectively reduced viral shedding upon non-lethal homologous viral challenge, but two doses of split virus vaccine was most effective at limiting viral replication and this was correlated with high influenza specific serum IgG concentrations. The two vaccine formulations induced different T helper profiles particularly after one dose of vaccine; split virus vaccine induced a type 2 bias response, whereas whole virus vaccine elicited a dominant type 1 response.

Mesh Headings (Keywords): Animals, Antibodies, Viral, Antibody Formation, Antibody-Producing Cells, Disease Models, Animal, Immunoglobulin G, Influenza Vaccines, Mice, Mice, Inbred BALB C, Orthomyxoviridae, Orthomyxoviridae Infections, Vaccines, Inactivated


Check for Full Text / PubMed Unique Identifier (PMID): 16839650


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.